Daily BriefsEvent-Driven

Event-Driven: Jinko Solar, SK Telecom, JMT Network Services, Microstrategy Inc Cl A, Suchuang Gas Corp, Bausch Health Companies and more

In today’s briefing:

  • STAR50 Index Rebalance Preview: 3 Changes or 5? It Depends…
  • Overlooked Aspect About MSCI’s SKT Foreign Room Calculation
  • SET50 Index Rebalance Preview: +JMT, JMART, BJC / -RATCH, STGT, IRPC
  • Microstrategy: More Losses For Bitcoin Spruiker
  • Suchuang Gas’ Scheme Meeting on 10 June Is a Welcome Exit from the Ongoing Share Suspension
  • SpinTalk: The Bausch Corporate Overhaul Is More Illusory Than Substantive At Least for Now

STAR50 Index Rebalance Preview: 3 Changes or 5? It Depends…

By Brian Freitas


Overlooked Aspect About MSCI’s SKT Foreign Room Calculation

By Sanghyun Park

  • The MSCI does not have a rule on how to treat DRs in the foreign room calculation. It only considers the proportion of shares AVAILABLE to foreign investors.
  • Unlike KT in 2019, SKT ADRs are not traded at a premium. It means that the MSCI may treat a portion of SKT ADRs as Still AVAILABLE Shares.
  • For this reason, it cannot be concluded that SKT will be deleted simply because it is below 3.75%.

SET50 Index Rebalance Preview: +JMT, JMART, BJC / -RATCH, STGT, IRPC

By Brian Freitas


Microstrategy: More Losses For Bitcoin Spruiker

By David Blennerhassett

  • Microstrategy Inc Cl A (MSTR US) reported a net loss of $155.6mn in the fourth quarter, compared to the net loss of $124.3mn in the 4Q21. 
  • MSTR took a non-cash digital asset impairment charge of $170.1mn in the first quarter, up from $146.6mn in the 4Q21. 
  • A bet on MSTR is a bet on bitcoin. Yet MSTR is down 37% YTD, compared to ~20% for bitcoin. 

Suchuang Gas’ Scheme Meeting on 10 June Is a Welcome Exit from the Ongoing Share Suspension

By Arun George

  • The scheme document is out with the Court meeting scheduled for 10 June. The IFA considers the offer to be fair and reasonable. Suchuang Gas Corp (1430 HK) remains suspended.
  • Key conditions are the headcount test and approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). 
  • Excluding the irrecovables, no shareholder holds a blocking stake. As the timeframe to fulfil the resumption guidance remains highly uncertain, the offer is a welcome exit opportunity. 

SpinTalk: The Bausch Corporate Overhaul Is More Illusory Than Substantive At Least for Now

By Robert Sassoon

  • Bausch Health Companies (BHC US)‘s share price reversal over the past year has eliminated the substantial  gains achieved after it announced plans for a major corporate overhaul in August 2020.
  • No substantive change to BHC’s current holding company structure and leverage ratio will result from the imminent execution of the Bausch & Lomb IPO which is less transformational than expected.
  • The potential for a more value-creating overhaul remains, but timing is uncertain. Until the relevant catalysts come into play, we expect the BHC share price to tread water at best.

Before it’s here, it’s on Smartkarma